Thyroid News

Advancing age may be associated with reduced risk for papillary thyroid tumor growth under active surveillance, according to findings published in JAMA Otolaryngology Head & Neck Surgery.

Free 25-hydroxyvitamin D levels may provide a more accurate vitamin D status than total levels to distinguish normocalcemic primary hyperparathyroidism and secondary hyperparathyroidism, according to findings published in Endocrine Practice.

An increased rate of thyroid cancers observed among firefighters who responded to the 9/11 World Trade Center attack may be associated with heightened surveillance rather than an increase in disease, according to findings published in JAMA Internal Medicine.

Most fine-needle aspiration procedures for thyroid nodules can be safely delayed for 6 months or longer during the COVID-19 pandemic; data show such delays do not influence the long-term prognosis for common forms of thyroid cancer, according to an editorial published in Clinical Thyroidology.

Alan J. Garber, MD, PhD, MACE, a leading expert on diabetes and cardiometabolic disorders and long-time chief medical editor of Endocrine Today, died Thursday, April 9.

High-risk adults with active thyroid eye disease, such as smokers, women and older adults, experienced a reduction in outward bulging of the eye at 24 weeks that was similar to adults at lower risk for the disease, according to findings accepted for presentation at the Endocrine Society Annual Meeting.

IMVT-1401, a thyroid eye disease treatment candidate, showed a 65% improvement in IgG levels in a phase 2a proof-of-concept study, Immunovant announced in a press release.

Korean adults who reported being daily smokers and drinkers were less likely to develop thyroid cancer during 5 years of follow-up compared with never-smokers and never-drinkers, according to findings published in Thyroid.

Women with obesity and primary hypothyroidism prescribed levothyroxine continued to have a lower resting energy expenditure, a measurement of whole-body metabolism, when compared with similar women who were euthyroid, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

Aggressive papillary thyroid carcinoma variants appeared associated with a wide range of survival outcomes, suggesting greater emphasis should be placed on tailored treatment approaches for patients with histologically and prognostically distinct subtypes, according to study results published in JAMA Oncology.